Stocks and Investing
Stocks and Investing
Mon, May 11, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sun, May 10, 2020
[ 12:00 AM ] - United States, WOPRAI
Fri, May 8, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kennen MacKay Maintained (ABEO) at Buy with Decreased Target to $175 on, May 8th, 2020
Kennen MacKay of RBC Capital, Maintained "Abeona Therapeutics Inc." (ABEO) at Buy with Decreased Target from $275 to $175 on, May 8th, 2020.
Kennen has made no other calls on ABEO in the last 4 months.
There is 1 other peer that has a rating on ABEO. Out of the 1 peers that are also analyzing ABEO, 0 agree with Kennen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kennen
- Mani Foroohar of "SVB Leerink" Maintained at Buy and Held Target at $150 on, Monday, February 10th, 2020
Contributing Sources